EWTX Edgewise Therapeutics, Inc.
Fundamentals / CIK 0001710072 / USDEdgewise Therapeutics, Inc. reported $1.78B in total assets and net income of $1.01B through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open EWTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$218.2M Operating profit
-
Net Income FY 2025$1.01B GAAP bottom line
-
Diluted EPS FY 2025$8.35 Split-adjusted
-
Free Cash Flow FY 2025-$202.3M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$68.68M Total debt: $3.38M
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Research & Development | $151.4M | $127.0M | $90.91M | $54.03M | $32.19M | $14.98M |
| Total Operating Expenses | $191.4M | $158.8M | $114.4M | $71.66M | $43.22M | $17.19M |
| Operating Income | -$191.4M | -$158.8M | -$114.4M | -$71.66M | -$43.22M | -$17.19M |
| EBITDA | -$189.3M | -$156.8M | -$112.8M | -$71.29M | -$42.94M | -$17.01M |
| Interest Income | $23.61M | $25.02M | $14.19M | $4.02M | $402K | $69K |
| Income Before Tax | -$167.8M | -$133.8M | -$100.2M | -- | -- | -- |
| Income Tax Expense | $4.0K | $3.0K | $4.0K | $0 | $0 | -- |
| Net Income | -$167.8M | -$133.8M | -$100.2M | -$67.64M | -$42.81M | -$17.12M |
| Basic EPS | -$1.63 | -$1.45 | -$1.57 | -$1.26 | -$1.14 | -$23.17 |
| Diluted EPS | -$1.63 | -$1.45 | -$1.57 | -$1.26 | -$1.14 | -$23.17 |
| Basic Shares Outstanding | 102.9M | 92.4M | 63.7M | 53.6M | 37.5M | 739.0K |
| Diluted Shares Outstanding | 102.9M | 92.4M | 63.7M | 53.6M | 37.5M | 739.0K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $31.57M | $47.55M | $42.65M | $43.59M | $37.48M | $33.56M | $36.76M | $36.37M |
| Total Operating Expenses | $46.14M | $61.94M | $54.12M | $55.98M | $46.86M | $42.61M | $45.96M | $45.54M |
| Operating Income | -$46.14M | -$61.94M | -$54.12M | -$55.98M | -$46.86M | -$42.61M | -$45.96M | -$45.54M |
| EBITDA | -$45.64M | -$61.44M | -$53.58M | -$55.45M | -$46.36M | -$42.11M | -$45.45M | -$44.96M |
| Interest Income | $16.50M | $4.62M | $5.10M | $5.76M | $6.19M | $6.50M | $5.16M | $5.88M |
| Income Before Tax | $1.32B | -- | -- | -- | -$40.67M | -- | -- | -- |
| Income Tax Expense | $155.3M | -- | -- | -- | -- | -- | -- | -- |
| Net Income | $1.17B | -$57.33M | -$49.01M | -$50.22M | -$40.67M | -$36.12M | -$40.80M | -$39.66M |
| Basic EPS | $10.71 | -$0.53 | -$0.46 | -- | -$0.39 | -$0.34 | -$0.43 | -- |
| Diluted EPS | $9.65 | -$0.53 | -$0.46 | -- | -$0.39 | -$0.34 | -$0.43 | -- |
| Basic Shares Outstanding | 108.9M | 107.7M | 107.1M | -- | 105.5M | 104.9M | 95.1M | -- |
| Diluted Shares Outstanding | 120.9M | 107.7M | 107.1M | -- | 105.5M | 104.9M | 95.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $61.15M | $41.67M | $86.10M | $21.99M | $15.57M | $104.9M |
| Cash & Short-Term Investments | $61.15M | $41.67M | $86.10M | $21.99M | $15.57M | $104.9M |
| Total Current Assets | $543.4M | $475.5M | $327.0M | $357.0M | $283.8M | $129.6M |
| Property, Plant & Equipment, Net | $7.83M | $9.50M | $10.44M | $8.53M | $912K | $516K |
| Other Non-Current Assets | -- | $262K | $348K | $251K | $548K | $975K |
| Total Non-Current Assets | $9.22M | $11.33M | $13.04M | $10.10M | $1.46M | $1.49M |
| Total Assets | $552.6M | $486.8M | $340.0M | $367.1M | $285.2M | $131.1M |
| Accounts Payable | $6.01M | $5.58M | $4.03M | $6.11M | $3.84M | $1.58M |
| Total Current Liabilities | $27.37M | $23.86M | $16.77M | $16.59M | $10.52M | $4.34M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $329K | -- |
| Total Non-Current Liabilities | $2.98M | $3.74M | $4.43M | $3.80M | $329K | $0 |
| Total Liabilities | $30.35M | $27.60M | $21.20M | $20.39M | $10.85M | $4.34M |
| Total Debt (incl. Leases) | $3.99M | $4.74M | $5.41M | $4.41M | -- | -- |
| Common Stock | $10K | $9.0K | $7.0K | $6.0K | $5.0K | -- |
| Retained Earnings | -$546.4M | -$378.6M | -$244.8M | -$144.6M | -$76.96M | -$34.15M |
| Accumulated Other Comp. Income | $677K | $420K | $99K | -$1.35M | -$514K | -- |
| Total Stockholders' Equity | $522.3M | $459.2M | $318.8M | $346.7M | $274.4M | -$33.42M |
| Total Equity | $522.3M | $459.2M | $318.8M | $346.7M | $274.4M | -$33.42M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $68.68M | $72.32M | $33.21M | $61.15M | $46.00M | $43.40M | $49.92M | $41.67M |
| Cash & Short-Term Investments | $68.68M | $72.32M | $33.21M | $61.15M | $46.00M | $43.40M | $49.92M | $41.67M |
| Total Current Assets | $1.77B | $471.5M | $509.8M | $543.4M | $573.9M | $603.3M | $443.2M | $475.5M |
| Property, Plant & Equipment, Net | $6.33M | $6.89M | $7.40M | $7.83M | $8.13M | $8.60M | $8.99M | $9.50M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | $695K | $262K |
| Total Non-Current Assets | $7.55M | $8.17M | $8.73M | $9.22M | $9.57M | $10.08M | $11.21M | $11.33M |
| Total Assets | $1.78B | $479.7M | $518.5M | $552.6M | $583.5M | $613.3M | $454.4M | $486.8M |
| Accounts Payable | $9.64M | $4.67M | $7.29M | $6.01M | $6.16M | $8.32M | $8.79M | $5.58M |
| Deferred Revenue (Current) | $5.20M | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $144.1M | $29.04M | $22.54M | $27.37M | $21.65M | $20.90M | $21.11M | $23.86M |
| Deferred Revenue (Non-Current) | $900K | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $888K | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $3.25M | $2.57M | $2.78M | $2.98M | $3.17M | $3.37M | $3.56M | $3.74M |
| Total Liabilities | $147.4M | $31.61M | $25.32M | $30.35M | $24.82M | $24.26M | $24.67M | $27.60M |
| Total Debt (incl. Leases) | $3.38M | $3.59M | $3.79M | $3.99M | $4.18M | $4.37M | $4.56M | $4.74M |
| Common Stock | $10K | $10K | $10K | $10K | $10K | $10K | $9.0K | $9.0K |
| Retained Earnings | $513.4M | -$652.7M | -$595.4M | -$546.4M | -$496.2M | -$455.5M | -$419.4M | -$378.6M |
| Accumulated Other Comp. Income | -$5.60M | -$500K | -$252K | $677K | $701K | $204K | $401K | $420K |
| Total Stockholders' Equity | $1.63B | $448.1M | $493.2M | $522.3M | $558.6M | $589.1M | $429.7M | $459.2M |
| Total Equity | $1.63B | $448.1M | $493.2M | $522.3M | $558.6M | $589.1M | $429.7M | $459.2M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$167.8M | -$133.8M | -$100.2M | -$67.64M | -$42.81M | -$17.12M |
| Depreciation & Amortization | $2.08M | $2.07M | $1.55M | $368K | $272K | $185K |
| Stock-Based Compensation | $34.75M | $24.71M | $17.56M | $10.92M | $4.40M | $354K |
| Change in Payables | $272K | $1.74M | -$92K | $47K | $2.65M | $521K |
| Operating Cash Flow | -$143.8M | -$109.0M | -$91.95M | -$52.63M | -$33.51M | -$14.63M |
| Capital Expenditure | -$256K | -$1.31M | -$5.75M | -$5.55M | -$668K | -$203K |
| Free Cash Flow | -$144.1M | -$110.3M | -$97.69M | -$58.18M | -$34.17M | -$14.84M |
| Purchases of Investments | -$527.2M | -$477.1M | -$255.9M | -$292.4M | -$288.2M | -$24.18M |
| Investing Cash Flow | -$32.79M | -$184.7M | $102.9M | -$70.58M | -$242.2M | -$24.38M |
| Common Stock Issued | $187.4M | $239.1M | $52.62M | $129.2M | -- | -- |
| Financing Cash Flow | $196.1M | $249.3M | $53.17M | $129.6M | $186.4M | $120.3M |
| Net Change in Cash | $19.48M | -$44.43M | $64.10M | $6.43M | -$89.35M | $81.26M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $1.17B | -$57.33M | -$49.01M | -$50.22M | -$40.67M | -$36.12M | -$40.80M | -$39.66M |
| Depreciation & Amortization | $500K | $500K | $537K | $525K | $500K | $500K | $513K | $577K |
| Stock-Based Compensation | $8.56M | $9.36M | $8.71M | $9.88M | $8.09M | $7.73M | $9.06M | $7.74M |
| Change in Payables | $6.60M | $781K | $1.45M | -$303K | -$2.13M | -$151K | $2.86M | $92K |
| Operating Cash Flow | -$78.29M | -$42.47M | -$42.54M | -$38.59M | -$34.78M | -$32.58M | -$37.87M | -$26.96M |
| Capital Expenditure | -$17K | -$32K | -$260K | -$73K | -$89K | -$50K | -$44K | -$274K |
| Free Cash Flow | -$78.31M | -$42.50M | -$42.80M | -$38.66M | -$34.87M | -$32.63M | -$37.91M | -$27.23M |
| Purchases of Investments | -$1.40B | -$53.09M | -$110.2M | -$74.28M | -$67.00M | -$263.8M | -$122.2M | -$63.18M |
| Investing Cash Flow | $59.67M | $78.49M | $2.43M | $49.76M | $35.72M | -$162.2M | $43.90M | $20.92M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| Financing Cash Flow | $14.98M | $3.09M | $12.17M | $3.98M | $1.66M | $188.2M | $2.22M | $2.90M |
| Net Change in Cash | -$3.64M | $39.11M | -$27.94M | $15.14M | $2.60M | -$6.52M | $8.26M | -$3.14M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -32.1% | -29.1% | -31.4% | -19.5% | -15.6% | -- |
| Return on Assets (ROA) | -30.4% | -27.5% | -29.5% | -18.4% | -15.0% | -13.1% |
| Current Ratio | 19.85x | 19.93x | 19.50x | 21.53x | 26.97x | 29.86x |
| Quick Ratio | 2.23x | 1.75x | 5.13x | 1.33x | 1.48x | 24.16x |
| Debt to Equity | 0.01x | 0.01x | 0.02x | 0.01x | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 61.8% | -44.0% | -35.7% | -32.1% | -28.1% | -25.6% | -34.0% | -29.1% |
| Return on Assets (ROA) | 56.7% | -41.1% | -33.9% | -30.4% | -26.9% | -24.6% | -32.1% | -27.5% |
| Current Ratio | 12.30x | 16.24x | 22.61x | 19.85x | 26.51x | 28.87x | 20.99x | 19.93x |
| Quick Ratio | 0.48x | 2.49x | 1.47x | 2.23x | 2.13x | 2.08x | 2.36x | 1.75x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |